Oxford BioMedica (OTCMKTS:OXBDF) Shares Gap Down – Should You Sell?

Oxford BioMedica (OTCMKTS:OXBDF)’s stock price gapped down prior to trading on Thursday. The stock had previously closed at $7.65, but opened at $6.70. Oxford BioMedica shares last traded at $6.70, with a volume of 7,462 shares changing hands.

Wall Street Analyst Weigh In

Separately, Zacks Research raised Oxford BioMedica to a “hold” rating in a report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Hold rating. According to MarketBeat.com, the stock has an average rating of “Hold”.

Oxford BioMedica Stock Up 3.3%

The business’s fifty day moving average is $6.81 and its two-hundred day moving average is $7.60.

Oxford BioMedica Company Profile

Oxford BioMedica plc is a contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. The company works with biotechnology and pharmaceutical customers to develop, manufacture and test viral vectors and other biological materials used in advanced therapies.

Its capabilities include process and analytical development, clinical and commercial manufacturing, quality control, regulatory support and technology transfer. Oxford BioMedica has particular expertise in lentiviral vectors, which are used to deliver genetic material into cells, and also provides services involving adeno-associated virus and other viral-vector platforms.

Founded in 1995 and headquartered in Oxford, England, the company serves customers internationally across the pharmaceutical and biotechnology industries.